These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8648397)

  • 1. Radioimmunotherapy: recent results and future directions.
    Wilder RB; DeNardo GL; DeNardo SJ
    J Clin Oncol; 1996 Apr; 14(4):1383-400. PubMed ID: 8648397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
    Ma D; McDevitt MR; Barendswaard E; Lai L; Curcio MJ; Pellegrini V; Brechbiel MW; Scheinberg DA
    Leukemia; 2002 Jan; 16(1):60-6. PubMed ID: 11840264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer radioimmunotherapy.
    Sharkey RM; Goldenberg DM
    Immunotherapy; 2011 Mar; 3(3):349-70. PubMed ID: 21395378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of clinical radioimmunotherapy.
    Pohlman B; Sweetenham J; Macklis RM
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):445-61. PubMed ID: 16503861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of therapy of solid tumors.
    Jhanwar YS; Divgi C
    J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.
    O'Donnell RT; Shen S; Denardo SJ; Wun T; Kukis DL; Goldstein DS; Denardo GL
    Anticancer Res; 2000; 20(5C):3647-55. PubMed ID: 11268433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical radioimmunotherapy.
    Knox SJ; Meredith RF
    Semin Radiat Oncol; 2000 Apr; 10(2):73-93. PubMed ID: 10727597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunotherapy of lymphomas and leukemias].
    Rain JD; Billotey C
    Pathol Biol (Paris); 1998 May; 46(5):341-5. PubMed ID: 9769896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era for radiolabeled antibodies in cancer?
    DeNardo SJ; Kroger LA; DeNardo GL
    Curr Opin Immunol; 1999 Oct; 11(5):563-9. PubMed ID: 10508716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunotherapy of cancer: using monoclonal antibodies to target radiotherapy.
    Illidge TM; Brock S
    Curr Pharm Des; 2000 Sep; 6(14):1399-418. PubMed ID: 10903400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?
    DeNardo GL; DeNardo SJ; Balhorn R
    Cancer Biother Radiopharm; 2008 Aug; 23(4):383-97. PubMed ID: 18771343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
    J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
    Postema EJ; Frielink C; Oyen WJ; Raemaekers JM; Goldenberg DM; Corstens FH; Boerman OC
    Cancer Biother Radiopharm; 2003 Aug; 18(4):525-33. PubMed ID: 14503946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
    Sharkey RM; Goldenberg DM
    J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of malignancies.
    Reilly RM
    Clin Pharm; 1991 May; 10(5):359-75. PubMed ID: 2049898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
    Postema EJ; Boerman OC; Oyen WJ; Raemaekers JM; Corstens FH
    Eur J Nucl Med; 2001 Nov; 28(11):1725-35. PubMed ID: 11702116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure of incurable lymphoma.
    DeNardo GL; Sysko VV; DeNardo SJ
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S46-56. PubMed ID: 16979440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma.
    Juweid ME; Stadtmauer E; Hajjar G; Sharkey RM; Suleiman S; Luger S; Swayne LC; Alavi A; Goldenberg DM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3292s-3303s. PubMed ID: 10541378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy of hematological cancer: problems and progress.
    Jurcic JG; Scheinberg DA
    Clin Cancer Res; 1995 Dec; 1(12):1439-46. PubMed ID: 9815942
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
    Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
    Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.